Study S002263

A Bicentric Open-label, Randomized, Two-parallel-group Study Investigating the Impact of Combined Lantus Insulin Glargine) and Lyxumia(Lixisenatide) on Insulin Secretion and Gastric Emptying in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled on Diet and Oral Antidiabetic Medication

ClinicalTrials.gov record

Registration

Registration: NCT01910194
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 39
Start: 2013-12
Primary completion: 2014-10
Lead sponsor: Profil Institut für Stoffwechselforschung GmbH
Conditions: Diabetes Mellitus
Interventions: DRUG:Luyxumia versus Lantus
Results posted: FALSE

Registered primary outcomes

AUCISEC(0-10min) [Within 0 to 10 min after iv glucose challenge]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.